Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details)

v3.21.2
Stockholders' Equity (Deficit) - Schedule of Stock Options Activity (Details) - $ / shares
 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Equity [Abstract]    
Number of Shares, Outstanding, Beginning balance 579,584 580,171
Number of Shares, Granted   19,272
Number of Shares, Exercised (22,760) (5,249)
Number of Shares, Forfeited and cancelled (25,619) (14,610)
Number of Shares, Outstanding, Ending balance 531,205 579,584
Number of Shares, Exercisable, Ending balance 490,323 454,156
Weighted Average Exercise Price, Outstanding, Beginning balance $ 11.00 $ 11.05
Weighted Average Exercise Price, Granted   8.45
Weighted Average Exercise Price, Exercised 6.16 4.68
Weighted Average Exercise Price, Forfeited and cancelled 14.62 11.86
Weighted Average Exercise Price, Outstanding, Ending balance 11.02 11.00
Weighted Average Exercise Price, Exercisable, Ending balance $ 10.87 $ 10.77
Weighted Average Remaining Contract Term (years), Outstanding, Beginning balance 7 years 6 months 18 days 8 years 7 months 2 days
Weighted Average Remaining Contract Term (years), Outstanding, Ending balance 6 years 8 months 23 days 7 years 6 months 18 days
Weighted Average Remaining Contract Term (years), Exercisable, Ending balance 6 years 7 months 21 days 7 years 3 months 8 days